Pharmafile Logo

News and Press Releases

ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement

License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services 1 October 2024 -- Dublin, Ireland, and Montreal, Canada -- ERS Genomics...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: October 1, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

Successful Conclusion of London Biotechnology Show, Leaves Attendees Highly Satisfied

10 May 2024 -- London, UK -- The curtain has closed on the debut London Biotechnology Show 2024, leaving attendees thoroughly impressed by the seamless delivery of promised content and...

Category: Biotechnology
Posted: May 10, 2024

London Biotechnology Show
info@londonbiotechshow.com

Nonacus launches test for comprehensive genomic profiling, integrated with bioinformatics and analysis software

2 April 2024 -- Birmingham, UK -- Genetic testing company, Nonacus, has launched GALEAS Tumor, a next generation sequencing (NGS) test that provides comprehensive genomic profiling of tumours, allowing clinicians...

Category: Biotechnology
Posted: April 2, 2024

Nonacus
info@nonacus.com
Unit 5, Quinton Business Park, 11 Ridgeway, Quinton, Birmingham B32 1AF, United Kingdom

Verisense Health Adopts Datavant’s Data Connectivity Platform to Expand its Digital Health Panel’s RWD Sources

Datavant’s privacy-preserving record linkage technology will allow Verisense Health’s digital health data to generate richer patient insights. 6 February 2024 -- Massachusetts, US -- Verisense Health Inc, a digital health...

Category: Biotechnology
Posted: February 7, 2024

Verisense
info@verisense.net
810 Memorial Dr, Suite 109 Cambridge, MA 02139 USA